Jim Simons
LTRN icon

Jim Simons’s Lantern Pharma LTRN Stock Holding History

Jim Simons’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
116,000
+5,600
+5% +$15.7K ﹤0.01% 2955
2025
Q4 		$335K Buy
110,400
+10,300
+10% +$38.3K ﹤0.01% 2722
2025
Q3 		$435K Buy
100,100
+9,500
+10% +$39.7K ﹤0.01% 2855
2025
Q2 		$286K Buy
90,600
+1,800
+2% +$6.08K ﹤0.01% 3059
2025
Q1 		$314K Buy
88,800
+1,500
+2% +$6.22K ﹤0.01% 2917
2024
Q4 		$278K Buy
87,300
+3,300
+4% +$11.3K ﹤0.01% 3070
2024
Q3 		$308K Buy
84,000
+2,200
+3% +$9.06K ﹤0.01% 2974
2024
Q2 		$382K Buy
81,800
+16,100
+25% +$96.8K ﹤0.01% 2812
2024
Q1 		$578K Buy
65,700
+21,900
+50% +$117K ﹤0.01% 2802
2023
Q4 		$187K Buy
43,800
+5,700
+15% +$20.1K ﹤0.01% 3151
2023
Q3 		$130K Sell
38,100
-6,800
-15% -$30.9K ﹤0.01% 3194
2023
Q2 		$253K Buy
44,900
+20,300
+83% +$105K ﹤0.01% 3201
2023
Q1 		$119K Buy
24,600
+3,500
+17% +$18.4K ﹤0.01% 3434
2022
Q4 		$127K Sell
21,100
-200
-0.9% -$1K ﹤0.01% 3557
2022
Q3 		$102K Sell
21,300
-800
-4% -$4.3K ﹤0.01% 3593
2022
Q2 		$126K Buy
22,100
+11,400
+107% +$68K ﹤0.01% 3787
2022
Q1 		$77K Buy
+10,700
New +$71.5K ﹤0.01% 3836

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Jim Simons's LTRN Position: Q1 2026 in Review

Jim Simons increased its Lantern Pharma (LTRN) stake by 5.1% in Q1 2026, buying an estimated $15.7K and bringing the position to 116,000 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Jim Simons first reported a position in LTRN in Q1 2022 and has held it in 17 quarters since. The position peaked at $578K in Q1 2024. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Jim Simons held 116,000 shares of Lantern Pharma worth $159K as of Q1 2026.
  • Jim Simons bought 5,600 Lantern Pharma shares in Q1 2026, an estimated $15.7K.
  • Lantern Pharma made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2955 holding.
  • Jim Simons first reported a position in Lantern Pharma in Q1 2022 and has held it in 17 quarters since.
  • Jim Simons's Lantern Pharma position peaked at $578K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.